How many employees work at Immunitas Therapeutics?

Immunitas Therapeutics, Inc. has approximately 18 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Immunitas Therapeutics’s total headcount has declined 20.6% from 22 employees in 2023 to 18 in 2026.

Data source: Revelio LabsCoverage: Global workforce, 20232026Published August 2026

Is Immunitas Therapeutics hiring right now?

No, Immunitas Therapeutics is not actively hiring. Immunitas Therapeutics had 0 active job postings in 2026, a 0.0% no change from 2025 see job openings & hiring trends.

About Immunitas Therapeutics’s Workforce

Immunitas Therapeutics, Inc. is a Biotech and Healthcare Services company that employs 18 people worldwide as of March 2026. It is the 8th-largest by headcount among its peers. Founded in 2019, the company is headquartered in Waltham, Massachusetts.

Immunitas Therapeutics's workforce has declined 20.6% from 2023 to 2026, down 59.1% year over year in 2026. It fell to a low of 18 in 2026 Q1 before recovering. Its workforce is concentrated most in North America (100.0%).

Immunitas Therapeutics's functional groups are Engineering (54.1%), Finance and Operations (34.6%), and Sales and Marketing (11.3%). The average salary is $211,774, highest in North America at a median of $172,000, up 48.1% year over year in 2026.

Immunitas Therapeutics's hiring activity held steady in 2026. Overall employee sentiment is positive but declining.

Sourced from Revelio Labs workforce data.

Headquarters
Waltham, Massachusetts
Founded
2019
Industry
Biotech and Healthcare Services
Employees
18
YoY
-59.1% (-19)

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Immunitas Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics

Immunitas Therapeutics Annual Employee Count (2023-2026)

Interactive chart of Immunitas Therapeutics annual worldwide employee count from 2023 to 2026.
  • Immunitas Therapeutics had 18 employees in 2026, a 59.1% decline (-19) from 2025.
  • Immunitas Therapeutics had 21 employees in 2025, a 46.4% decline (-19) from 2024.
  • Immunitas Therapeutics had 40 employees in 2024, a 51.4% increase (+17) from 2023.
  • Immunitas Therapeutics had 23 employees in 2023, a 39.7% decline (-18) from 2022.

Immunitas Therapeutics's total workforce has declined from 22 employees in 2023 to 18 in 2026. Immunitas Therapeutics's headcount peaked at 40 in 2024.

Immunitas Therapeutics, Inc. quarterly employee count

YearQtrEmployeesYoY ChangeYoY %
2026Q118-19-59.1%
2025Q421-19-46.4%
2025Q323-7-3.6%
2025Q225-5-3.7%
2025Q137+13+49.5%
2024Q440+17+51.4%
2024Q330+8+19.6%
2024Q230+8+20.0%
2024Q124-15-33.7%
2023Q423-18-39.7%
2023Q322-26-39.6%
2023Q222-25-40.2%

See Immunitas Therapeutics's complete headcount history, including quarterly breakdowns.

Get the Data

Immunitas Therapeutics Employee Count by Region (2026)

North America accounts for the largest share of Immunitas Therapeutics's global workforce with approximately 100% of total employees.

Immunitas Therapeutics employees by region

RegionEmployees% of Total
North America18100.0%

Drill into city-level data, hiring trends by region, and historic geographic shifts.

Unlock Geographic Data

Immunitas Therapeutics Employee Count by Department (2026)

Immunitas Therapeutics's employee groups are Engineering (54.1%), Finance and Operations (34.6%), and Sales and Marketing (11.3%).

Immunitas Therapeutics employees by department

DepartmentEmployees% of Total
Engineering1054.1%
Finance and Operations634.6%
Sales and Marketing211.3%

Compare Immunitas Therapeutics's department mix to industry peers.

See Full Data

Immunitas Therapeutics Employee Salary by Region (2026)

Immunitas Therapeutics's average employee salary is $211,774 globally. Employees in North America receive the highest compensation.

Immunitas Therapeutics median employee salary by region (USD)

RegionMedian Salary
North America$172,000

Unlock salary by role, level, and city — and compare to Immunitas Therapeutics's industry peers.

Unlock Salary Data

Immunitas Therapeutics Job Openings and Hiring Trends (2023-2026)

Interactive chart of Immunitas Therapeutics annual active job postings from 2023 to 2026.
  • Immunitas Therapeutics had 0 active job postings in 2026, a 0% no change from 2025.
  • Immunitas Therapeutics had 0 active job postings in 2025, a 0% no change from 2024.
  • Immunitas Therapeutics had 0 active job postings in 2024, a 200.0% decline (-2) from 2023.
  • Immunitas Therapeutics had 2 active job postings in 2023, a 66.7% increase from 2022.
  • Hiring velocity in 2026: 0 new roles/month, up from 0 in 2025 and 0 in 2024.

Immunitas Therapeutics's hiring activity held steady in 2026.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

Immunitas Therapeutics Employee Sentiment (2026)

Revelio Labs tracks employee sentiment across Immunitas Therapeutics's workforce based on public professional data. Overall sentiment is positive and has declined year over year in 2026.

Overall

NegativePositive

Unlock the full sentiment breakdown by department, tenure, and trend over time.

Unlock Sentiment

Similar Companies

Frequently Asked Questions About Immunitas Therapeutics

How fast is Immunitas Therapeutics growing?
In 2026, Immunitas Therapeutics's headcount shrank 59.1% to 18 employees, down from 37 in 2025.
See the full headcount history
Where are Immunitas Therapeutics employees located?
Most Immunitas Therapeutics employees are based in North America (100.0% of headcount).
Explore where the workforce is based
What is the average salary at Immunitas Therapeutics?
The average employee salary at Immunitas Therapeutics is approximately $211.8k per year.
Analyze the salary distribution
How many new job postings does Immunitas Therapeutics open per year?
In Q1 2026, Immunitas Therapeutics opened 0 new job postings. In 2025, Immunitas Therapeutics opened 0 new job postings — about 0 per month.
Track hiring trends by role
When was Immunitas Therapeutics founded and where is it headquartered?
Immunitas Therapeutics was founded in 2019 and is headquartered in Waltham, Massachusetts.
Compare Immunitas Therapeutics to industry peers

Speak with a workforce expert about Immunitas Therapeutics.

Book a Demo

See something that doesn't look right? Reach out and our team will review it.